1. Shin CM, Kim N, Yang HJ, et al. 2010; Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol. 44:e34–e39. DOI:
10.1097/MCG.0b013e3181a159c4. PMID:
19561529.
2. Kim SG, Jung HK, Lee HL, et al. 2013; Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol. 62:3–26. DOI:
10.4166/kjg.2013.62.1.3. PMID:
23954956.
Article
3. Malfertheiner P, Megraud F, O'Morain CA, et al. 2017; Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut. 66:6–30. DOI:
10.1136/gutjnl-2016-312288. PMID:
27707777.
4. Chey WD, Leontiadis GI, Howden CW, Moss SF. 2017; ACG clinical guideline:treatment of Helicobacter pylori infection. Am J Gastroenterol. 112:212–239. DOI:
10.1038/ajg.2016.563. PMID:
28071659.
5. Parsonnet J, Friedman GD, Vandersteen DP, et al. 1991; Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 325:1127–1131. DOI:
10.1056/NEJM199110173251603. PMID:
1891020.
6. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. 1991; Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 325:1132–1136. DOI:
10.1056/NEJM199110173251604. PMID:
1891021.
7. IARC. 7-14. June. 1994. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum. 61:p. 1–241. Lyon:
8. You WC, Brown LM, Zhang L, et al. 2006; Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 98:974–983. DOI:
10.1093/jnci/djj264. PMID:
16849680.
9. Wong BC, Lam SK, Wong WM, et al. 2004; Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 291:187–194. DOI:
10.1001/jama.291.2.187. PMID:
14722144.
10. Choi IJ, Kook MC, Kim YI, et al. 2018; Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 378:1085–1095. DOI:
10.1056/NEJMoa1708423. PMID:
29562147.
Article
12. Nam JH, Choi IJ, Cho SJ, et al. 2011; Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients. J Gastroenterol Hepatol. 26:1157–1163. DOI:
10.1111/j.1440-1746.2011.06717.x. PMID:
21392104.
Article
13. Correa P. 1992; Human gastric carcinogenesis: a multistep and multifactorial process--first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 52:6735–6740. PMID:
1458460.
14. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. 2014; Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 348:g3174. DOI:
10.1136/bmj.g3174. PMID:
24846275. PMCID:
PMC4027797.
Article
15. Li WQ, Zhang JY, Ma JL, et al. 2019; Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 366:l5016. DOI:
10.1136/bmj.l5016. PMID:
31511230. PMCID:
PMC6737461.
16. Ma JL, Zhang L, Brown LM, et al. 2012; Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 104:488–492. DOI:
10.1093/jnci/djs003. PMID:
22271764. PMCID:
PMC3309129.
Article
17. Pan KF, Zhang L, Gerhard M, et al. 2016; A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut. 65:9–18. DOI:
10.1136/gutjnl-2015-309197. PMID:
25986943.